Treating Early Stage Prostate Cancer
Treatment of prostate cancer needs to be individualized
Decisions regarding treatment options are often based on the disease stage and grade, gleason score, pre-treatment prostate specific antigen (PSA), and rate PSA rise, as well as the patient's age and life expectancy. In particular, the presence or absence of other significant medical problems is of greater importance than chronologic age.
Treatment depends on how large the tumor is, whether it has spread to other parts of your body, and your overall health. Some of the treatments are:
Please use the navigation to the left to learn more about these treatments.
To learn more about the doctors that comprise the Prostate Care Program team, click here.
Portions of these web pages are based in part on content originally developed by Drs. M. Sanda, N. Shah, K. Pienta and others for the website of the University of Michigan Comprehensive Cancer Center. They are based in part on Cancer Management: A Multidisciplinary Approach: Medical, Surgical and Radiation Oncology, chapter 17, "Prostate Cancer," by K. Pienta, MD, H. Sandler, MD, N. Shah, DO, and M. Sanda, MD. Published by PRR: Melville, NY, 2002.
